STAPHYLOCOCCUS AUREUS — all Canadian products
2 DINs
0 marketed/approved
0 in shortage
Every Health Canada Drug Identification Number whose active ingredient is STAPHYLOCOCCUS AUREUS, with holder, form, strength and current status, compared weekly against the Drug Product Database.
| DIN | Product | Company | Form | Route | Strength | Status | Shortage |
|---|---|---|---|---|---|---|---|
| 00316393 | MEGAVAC INJ | OMEGA LABORATORIES LIMITED | Liquid | Subcutaneous | STAPHYLOCOCCUS AUREUS 300 M; STAPHYLOCOCCUS ALBUS 300 M; STREPTOCOCCUS VIRIDANS 33 M; STREPTOCOCCUS PYOGENES 33 M; STREPTOCOCCUS NON-HEMOLYTIC 33 M; PNEUMOCOCCUS (VARIOUS TYPES MIXTURE) 75 M; NEISSERIA CATARRHALIS 75 M; KLEBSIELLA PNEUMONIAE 75 M; HEMOPHILUS INFLUENZAE 75 M | Cancelled Post Market | |
| 02216981 | MRV | HOLLISTER-STIER LABORATORIES LLC | Suspension | Intradermal; Subcutaneous | STAPHYLOCOCCUS AUREUS 1200 M; STREPTOCOCCUS (VIRIDANS AND NON-HEMOLYTIC) 200 M; STREPTOCOCCUS (DIPLOCOCCUS) PNEUMONIAE 150 M; NEISSERIA CATARRHALIS 150 M; KLEBSIELLA PNEUMONIAE 150 M; HEMOPHILUS INFLUENZAE 150 M | Cancelled Post Market |
Browse other molecules: